Anatomic pathology plays a vital role in the study, diagnosis, and treatment of diseases. It includes the examination of surgical samples extracted from the infected part of the body, i.e., biopsy and the examination of the whole body to diagnose the disease, i.e., autopsy. The organs or tissues are examined on the basis of microscopic, macroscopic, biochemical, immunologic, and molecular tests in order to diagnose the disease. Anatomic and clinical are the two branches of pathology. Clinical pathology involves the diagnosis of diseases by examination of blood, serum, or other body fluids. The worldwide market for anatomic pathology is gaining substantial momentum due to the rising use and effectiveness of biomarkers in diagnosing various disease including cancer.
The global anatomic pathology market is driven by the increasing incidence and prevalence of chronic diseases including infectious diseases, kidney or liver diseases, and cancer. Cancer cases are increasing exponentially worldwide, with maximum patients suffering from lung, prostate, colorectal, and breast cancer. Biomarkers are presenting a promising approach in the diagnosis of cancer and other diseases. The elevating use of biomarkers for the diagnosis of diseases is predicted to considerably accelerate the development of the anatomic pathology market. Additionally, the growing global geriatric population also plays a contributing role, as elderly individuals are more prone to infectious diseases, thereby demanding proper diagnosis for effective treatment. The developing health care infrastructure is also motivating the global anatomic pathology market.
With the rising number of chronic diseases, demand for anatomic pathology services and therefore biopsies is also increasing. Any failure to deal with the large number of biopsies or comply with recommendations for cancer cases or other sample handling or additional testing may pose a major challenge. Improvement in turnaround time is another critical element of management, which may restrain the market.
The global anatomic pathology market can be segmented on the basis of product type & services into the following categories: consumables, reagents, instruments, and services. The instruments segment can further be divided into the following sub-categories: tissue processors, slide strainers, microtomes, and others. In terms of application, the market can be split into the following groups: drug discovery, disease diagnosis, and others. Based on end-user, the market can be classified into the following sections: hospitals, diagnostic laboratories, and research organizations.
Geographically, the global anatomic pathology market is distributed over five major regions: North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. North America holds a major share in the market due to the growing elderly population, prevalence of lung cancer & other chronic diseases, increasing investments by government & academic research centers in diagnostic research, high attention to biomarkers research, and the presence of major players in this region. Asia Pacific is anticipated to witness growth during the forecast period due to the presence of emerging economies such as India, China, and Japan. The rising population in these countries and thereby the increasing chronic diseases & improved standards in health care services, growing demand for superior medical care, and the mounting awareness regarding the importance of anatomic pathology investigation among health practitioners are some of the factors motivating the market.
Key players in the anatomic pathology market include Leica Microsystems (Danaher Corporation), Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, Sakura Finetek USA, Quest Diagnostics Incorporated, NeoGenomics Laboratories, Inc., and Laboratory Corporation of America Holdings.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453